NEJM Ahead of Print: Latest Research & Early Access
Platelet-activating anti-platelet factor 4 (PF4) disorders are rare, immune-mediated hematologic conditions where antibodies attack PF4 proteins, causing paradoxical blood clotting and low platelet counts. Recent clinical data published this week ... Read More